Glenmark up 5% on Temasek investment plan
Glenmark Pharma gained over 5% after Singapore's state investment arm Temasek said that it will invest about $151 mn in the co.20-04-2015
20-04-2015
Glenmark Pharma, Temasek Holdings, Singapore, Aranda Investments (Mauritius)
Funds will be raised by way of issue of upto 108,00,000 equity shares of Re 1 each on preferential basis for cash to Aranda, a foreign portfolio investor20-04-2015
Glenmark: the benefits of raising equity
Glenmarks decision to raise funds is a surprise since well-performing pharmaceutical firms rarely raise equity19-04-2015
EGM on May 13, 2015
Glenmark Pharmaceuticals Ltd has informed BSE that an Extraordinary General Meeting (EGM) of the Company will be held on May 13, 2015.18-04-2015
Glenmark to raise Rs 945 cr from Temasek Holdings
The company is issuing upto 1.08 crore shares of Re 1 each for cash to Aranda Investments (Mauritius), a wholly-owned indirect subsidiary of Temasek Holdings18-04-2015
Glenmark to Raise Rs 945 Crore From Temasek Holdings
The company's board, which met today, has decided to raise funds by issuing upto 1.08 crore shares of Re 1 each for cash to Aranda Investments (Mauritius) Pte Ltd.17-04-2015
Outcome of Board Meeting (EGM on May 13, 2015)
Glenmark Pharmaceuticals Ltd has informed BSE regarding Outcome of Board Meeting held on April 17, 2015.17-04-2015
Glenmark Pharma hits record high
Analyst at Prabhudas Lilladher upgrades recommendation on the stock to 'buy' and increase target price to Rs 1,186.13-04-2015
Shareholding Pattern For March 31, 2015
Glenmark Pharmaceuticals Ltd has informed BSE about the Shareholding Pattern as on March 31, 2015.11-04-2015